Areas of Focus
- Pathophysiology of adrenal-source hypertension and precision medicine
- Adrenal development, pathophysiology, and regeneration
Work Experience
- 2016-2021 - University of Cambridge and Queen Mary University of London - Postdoctoral Researcher
- 2021-Present - Peking University Basic Medical School - Researcher/Associate Professor
Academic Background & Achievements
- Bachelor of Clinical Medicine: Guangzhou Medical University
- Master in Nephrology: Peking University, completed residency at Peking University First Hospital
- PhD in Medicine: University of Cambridge (2016)
- Postdoctoral Research: University of Cambridge and Queen Mary University of London (2016-2021)
Publications
- Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause, Zhou J*, Azizan EA*, Cabrera CP*, Fernandes-Rosa F*, Boulkroun S*, Argentesi G, et al., 2021
- Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues, Zhou J*, Lam BY*, Neogi SG, Yeo GS, et al., 2016
- DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion, Zhou J*, Shaikh H L*, Neogi SG, McFarlane I, et al., 2015
- LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal, Shaikh LH*, Zhou J*, Teo AE, Garg S, et al., 2015
- Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension, Azizan EA*, Poulsen H*, Tuluc P*, Zhou J*, Clausen MV, et al, 2013